MX351380B - Composiciones y metodos de vacuna de tipo ib de virus de diarrea viral de bovino. - Google Patents

Composiciones y metodos de vacuna de tipo ib de virus de diarrea viral de bovino.

Info

Publication number
MX351380B
MX351380B MX2013007584A MX2013007584A MX351380B MX 351380 B MX351380 B MX 351380B MX 2013007584 A MX2013007584 A MX 2013007584A MX 2013007584 A MX2013007584 A MX 2013007584A MX 351380 B MX351380 B MX 351380B
Authority
MX
Mexico
Prior art keywords
methods
viral diarrhea
bovine viral
virus type
diarrhea virus
Prior art date
Application number
MX2013007584A
Other languages
English (en)
Other versions
MX2013007584A (es
Inventor
Wade Weise Dale
Robert Harris James
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45531546&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX351380(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2013007584A publication Critical patent/MX2013007584A/es
Publication of MX351380B publication Critical patent/MX351380B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a composiciones inmunogénicas que comprenden un tipi Ib de virus de diarrea viral vivo, modificado de bovino (BVDV-Ib), y métodos para su uso en la formulación y administración de agentes farmacéuticos terapéuticos y profilácticos. En particular, la invención proporciona composiciones inmunogénicas y métodos para prevenir, tratar, manejar, y/o mejorar una infección viral o microbiana, o uno o más síntomas de la misma, incluyendo, por ejemplo, aquellas infecciones que dan surgimiento a fiebre de embarque, complejo de enfermedad respiratoria de bovino, y/o diarrea viral de bovino, particularmente en animales susceptibles o infectados.
MX2013007584A 2010-12-27 2011-12-21 Composiciones y metodos de vacuna de tipo ib de virus de diarrea viral de bovino. MX351380B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061427361P 2010-12-27 2010-12-27
PCT/US2011/066384 WO2012092053A1 (en) 2010-12-27 2011-12-21 Bovine viral diarrhea virus type 1b vaccine compositions and methods

Publications (2)

Publication Number Publication Date
MX2013007584A MX2013007584A (es) 2013-10-17
MX351380B true MX351380B (es) 2017-10-12

Family

ID=45531546

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013007584A MX351380B (es) 2010-12-27 2011-12-21 Composiciones y metodos de vacuna de tipo ib de virus de diarrea viral de bovino.

Country Status (20)

Country Link
US (1) US20130280294A1 (es)
EP (1) EP2658570B1 (es)
JP (1) JP6053036B2 (es)
KR (1) KR101554080B1 (es)
CN (1) CN103347534B (es)
AU (1) AU2011352800B2 (es)
BR (1) BR112013016503A2 (es)
CA (1) CA2822825C (es)
CL (1) CL2013001877A1 (es)
CO (1) CO6761399A2 (es)
ES (1) ES2709190T3 (es)
MX (1) MX351380B (es)
NZ (1) NZ611531A (es)
PE (1) PE20140871A1 (es)
PH (1) PH12013501373B1 (es)
PL (1) PL2658570T3 (es)
PT (1) PT2658570T (es)
RU (1) RU2595873C2 (es)
SG (1) SG191396A1 (es)
WO (1) WO2012092053A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR084358A1 (es) * 2010-12-27 2013-05-08 Lilly Co Eli Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
US9480739B2 (en) * 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
CN107970443A (zh) * 2016-12-28 2018-05-01 浙江海隆生物科技有限公司 牛病毒性腹泻病毒e2蛋白亚单位疫苗组合物及其制备方法和应用
CN107823639B (zh) * 2017-11-10 2020-10-02 齐鲁动物保健品有限公司 牛病毒性腹泻病毒灭活疫苗及其制备方法
KR101960017B1 (ko) * 2018-04-09 2019-07-15 전북대학교 산학협력단 호흡기 질병의 원인체를 검출하기 위한 조성물 및 이를 이용한 방법
KR101960016B1 (ko) * 2018-04-09 2019-07-15 전북대학교 산학협력단 호흡기 질병의 원인체를 검출하기 위한 조성물 및 이를 이용한 방법
KR102101208B1 (ko) 2019-10-16 2020-04-17 주식회사 모투스 비산먼지 제거 기능이 있는 런닝머신
CN112034169A (zh) * 2020-08-27 2020-12-04 华威特（江苏）生物制药有限公司 用于检测牛病毒性腹泻病毒1型的直接免疫荧光试剂及其试剂盒
CN113207733B (zh) * 2021-05-28 2022-09-09 杨国胜 一种具有麻醉作用的畜牧用耳标
CN114634996B (zh) * 2022-02-28 2024-05-07 广东海大畜牧兽医研究院有限公司 用于检测牛呼吸道疾病的引物探针组合、试剂盒及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
DE3329892A1 (de) 1983-08-18 1985-03-07 Köster, Hubert, Prof. Dr., 2000 Hamburg Verfahren zur herstellung von oligonucleotiden
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
FR2596761B1 (fr) 1986-04-08 1988-05-20 Commissariat Energie Atomique Derives de nucleosides et leur utilisation pour la synthese d'oligonucleotides
US5491225A (en) 1991-12-19 1996-02-13 Hoffmann-La Roche Inc. PCR primers for detection of legionella species and methods for controlling visual intensity in hybridization assays
DE69518316T2 (de) * 1994-05-10 2001-03-29 American Home Products Corp., Madison Modifizierter,verbesserter,lebender brsv impfstoff
US7563449B2 (en) * 2003-04-21 2009-07-21 Pfizer Inc, Methods for reducing cattle reproductive diseases
US7361357B2 (en) * 2003-07-29 2008-04-22 Pfizer Inc. Safe mutant viral vaccines
BRPI0508941A (pt) * 2004-03-17 2007-08-14 Pharmacia & Upjohn Co Llc método de vacinação contra infecção de bvdv testicular
CA2616826A1 (en) * 2005-08-04 2007-02-15 Wyeth Stabilizers for veterinary vaccines
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
EP2026839A4 (en) * 2005-12-14 2009-04-01 Univ Oklahoma RNA VIRUS VACCINE AND METHODS

Also Published As

Publication number Publication date
CA2822825C (en) 2016-02-09
PE20140871A1 (es) 2014-07-19
CO6761399A2 (es) 2013-09-30
RU2013128921A (ru) 2015-02-10
RU2595873C2 (ru) 2016-08-27
CN103347534A (zh) 2013-10-09
AU2011352800B2 (en) 2015-09-03
JP2014502619A (ja) 2014-02-03
ES2709190T3 (es) 2019-04-15
NZ611531A (en) 2015-04-24
CL2013001877A1 (es) 2014-03-07
PL2658570T3 (pl) 2019-05-31
PH12013501373A1 (es) 2013-08-28
MX2013007584A (es) 2013-10-17
PH12013501373B1 (en) 2019-05-10
BR112013016503A2 (pt) 2018-05-22
EP2658570A1 (en) 2013-11-06
EP2658570B1 (en) 2018-11-28
AU2011352800A1 (en) 2013-06-20
JP6053036B2 (ja) 2016-12-27
PT2658570T (pt) 2019-02-08
SG191396A1 (en) 2013-08-30
KR20130109220A (ko) 2013-10-07
WO2012092053A1 (en) 2012-07-05
CN103347534B (zh) 2018-09-11
CA2822825A1 (en) 2012-07-05
US20130280294A1 (en) 2013-10-24
KR101554080B1 (ko) 2015-09-17

Similar Documents

Publication Publication Date Title
PH12013501373B1 (en) Bovine viral diarrhea virus type 1b vaccine compositions and methods
Ison Influenza prevention and treatment in transplant recipients and immunocompromised hosts
PH12019500289A1 (en) Vaccines directed against a human enteroviruses
PH12021550479A1 (en) Dengue vaccine unit dose and administration thereof
MX2009006178A (es) Vacuna contra salmonela.
NZ707328A (en) Virus-containing formulation and use thereof
EA201490610A1 (ru) Соединения и способы усиления врожденных иммунных ответов
BR112014004860A2 (pt) composições de anticorpo contra vírus da influenza
MX395525B (es) Composiciones inmunogenicas para usar en vacunas neumococicas.
WO2007124479A3 (en) Avian influenza viruses, vaccines, compositions, formulations, and methods
BR112014024159A2 (pt) Formulações de vacina oral específicas do local gastrintestinal , ativas no íleo e apêndice.
PH12015502230A1 (en) Novel viral replication inhibitors
BR112015017966A2 (pt) composições imunogênicas compreendendo vírus silificado e métodos de uso
BR112015004463A2 (pt) dispositivo hiperbárico e processos para produzir vacinas inativadas e para redobrar/solubilizar proteínas recombinantes
NZ618158A (en) Compositions and methods for administration of vaccines against dengue virus
WO2013104995A3 (en) Compositions and methods for treating viral infections
MY187472A (en) Multivalent vlp conjugates
MX2013003245A (es) Vacuna contra virus de diarrea viral de bovinos.
PH12015502128A1 (en) Novel dosing regimens of celgosivir for the treatment of dengue
WO2012078051A3 (en) IPN Vaccine
IN2014DN08927A (es)
CL2013002829A1 (es) Formulacion inmunogenica que contiene bcg vivas recombinantes que expresan antigenos de metapneumovirus (hmpv) en una suspension que se prepara a partir de un liofilizado sin la necesidad de adjuvante; su uso farmaceutico; vacuna contra hmpv.
BR112015013625A2 (pt) adjuvante de vacinação, preparação e vacinas contendo o mesmo
BR112013019850A8 (pt) Composições de vacina e seu uso no tratamento ou prevenção de doenças respiratórias infecciosas caninas
MX2014009022A (es) Virus de influenza c y vacuna.

Legal Events

Date Code Title Description
FG Grant or registration